Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01431079 · ClinicalTrials.gov registry record · Phase 4
A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men
A Phase 4 study of HPV Vaccine Acceptability, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT01431079: Completed Phase 4 study of HPV Vaccine Acceptability, sponsored by University of Cincinnati.
NCT01431079 is a Phase 4 study of HPV Vaccine Acceptability that has completed, run by University of Cincinnati. The registered enrollment target is 90 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01431079, a Phase 4 study of HPV Vaccine Acceptability, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purposes of this study are to (1) identify predictors of Human papillomavirus (HPV) vaccine acceptability among college men based on the Health Belief Model through focus groups, (2) triangulate focus group results with a prior quantitative study in developing an intervention based on the Health Belief Model to enhance HPV vaccine acceptability, and (3) test the efficacy of the above intervention based on the Health Belief Model by comparing it to a knowledge-based intervention. Approximately five focus groups with ten participants in each group with college students in the ages 18-25 years will be conducted at a large Midwestern University for the qualitative piece. Data will be analyzed for categories and triangulated with previous study to develop a theory based intervention. For the quantitative piece a randomized controlled design with 45 participants in each arm (theory based intervention and knowledge based intervention) will be implemented.
Primary Outcome
Before, after and one to three month following the health belief model based educational intervention and knowledge-based educational intervention the participants will be asked if they have taken the first dose of HPV vaccine and changes noted.
Conditions Studied
Interventions
- BEHAVIORAL HPV vaccine acceptability
Study Locations (1)
Ohio
- Manoj Sharma - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
What the finished NCT01431079 record still lists
NCT01431079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).
The record links to 1 condition, with HPV Vaccine Acceptability appearing as the primary indexed condition, and to 1 intervention - of which HPV vaccine acceptability is the first listed.
NCT01431079 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01431079 about?
NCT01431079 is a clinical study titled "A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men". The purposes of this study are to (1) identify predictors of Human papillomavirus (HPV) vaccine acceptability among college men based on the Health Belief Model through focus groups, (2) triangulate focus group results with a prior quantitative study in developing an intervention based on the Health...
What is the current status of trial NCT01431079?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2011-09. Estimated completion is 2012-08.
What conditions does trial NCT01431079 study?
This clinical trial studies the following conditions: HPV Vaccine Acceptability.
What interventions are being tested in trial NCT01431079?
The interventions under investigation include: HPV vaccine acceptability (BEHAVIORAL).
Who is sponsoring clinical trial NCT01431079?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01431079 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01431079's enrollment target sits among peer trials
90 886th of 2000 higher than 1,088 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia